|
|
 The Avecia-TriLink Alliance TriLink has teamed up with Avecia to enable you to easily transition from R&D and pre-clinical studies to clinical trials and commercial manufacture of therapeutic oligonucleotides. Working with this alliance minimizes your challenges and risks associated with transitioning from a research-grade vendor to an oligonucleotide development service and manufacturing company. We have harmonized our processes, so you can enjoy a smooth changeover when scaling up for clinical trials.
|
